Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Pharma-Bio Serv (PBSV) Equity Ratio (2016 - 2025)

Historic Equity Ratio for Pharma-Bio Serv (PBSV) over the last 16 years, with Q4 2025 value amounting to 0.87.

  • Pharma-Bio Serv's Equity Ratio rose 366.0% to 0.87 in Q4 2025 from the same period last year, while for Oct 2025 it was 0.87, marking a year-over-year increase of 366.0%. This contributed to the annual value of 0.87 for FY2025, which is 366.0% up from last year.
  • As of Q4 2025, Pharma-Bio Serv's Equity Ratio stood at 0.87, which was up 366.0% from 0.88 recorded in Q3 2025.
  • Pharma-Bio Serv's 5-year Equity Ratio high stood at 0.88 for Q3 2025, and its period low was 0.71 during Q1 2021.
  • Moreover, its 5-year median value for Equity Ratio was 0.8 (2023), whereas its average is 0.8.
  • As far as peak fluctuations go, Pharma-Bio Serv's Equity Ratio tumbled by 1271.75% in 2021, and later soared by 1199.4% in 2022.
  • Pharma-Bio Serv's Equity Ratio (Quarter) stood at 0.79 in 2021, then grew by 1.4% to 0.8 in 2022, then grew by 1.06% to 0.81 in 2023, then increased by 3.89% to 0.84 in 2024, then increased by 3.66% to 0.87 in 2025.
  • Its last three reported values are 0.87 in Q4 2025, 0.88 for Q3 2025, and 0.87 during Q2 2025.